Rest Of Europe Single-Use Bioreactors Market (2026-2031)
The Rest Of Europe Single-Use Bioreactors Market was valued at $225.6 Million in 2026 and projected to reach to $316.4 Million by 2031, representing a compound annual growth rate of 7.0%. Rest Of Europe's single-use bioreactors market is poised for steady expansion through 2031, driven by the region's growing biopharmaceutical sector and increasing preference for flexible manufacturing solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe Single-Use Bioreactors Market Trends and Insights
- Rest Of Europe represents a significant portion of the broader European bioreactor landscape, driven by increasing adoption of single-use technologies among biopharmaceutical manufacturers seeking operational flexibility and reduced contamination risks.
- The region's growth trajectory reflects rising investments in cell and gene therapy manufacturing, coupled with regulatory support for innovative production methods across multiple European nations. Rest Of Europe's 7.0% compound annual growth rate (CAGR) through 2031 underscores the region's commitment to modernizing biomanufacturing infrastructure.
- Rest Of Europe benefits from a robust network of contract manufacturing organizations (CMOs) and growing demand for personalized medicine platforms that leverage single-use bioreactor technology.
- The market expansion in Rest Of Europe is supported by increasing capital expenditure in life sciences facilities and heightened focus on supply chain resilience post-pandemic, positioning the region as a key growth hub for single-use bioreactor adoption..
Key Market Statistics
- CAGR (2026-2031) 7.0% CAGR
- Market Size, 2026 ~USD 225.6 Million
- Forecast, 2031 ~USD 316.4 Million
- Country Rest Of Europe
Rest Of Europe Single-Use Bioreactors Market Overview
Market Valuation Growth :
Rest Of Europe's single-use bioreactors market is valued at USD 225.6 million in 2026, with a projected expansion to USD 316.4 million by 2031, representing a steady 7% CAGR over the forecast period.
Regional Adoption Drivers :
Biopharmaceutical manufacturers across Rest Of Europe are increasingly adopting single-use bioreactor technologies to enhance operational flexibility, reduce capital expenditure, and minimize cleaning validation requirements compared to traditional stainless steel systems.
Market Position in Europe :
Rest Of Europe represents a significant portion of the broader European bioreactor landscape, with growing investments in biotech infrastructure and manufacturing capabilities driving demand for flexible, scalable production solutions.
Growth Trajectory :
The 7% CAGR for Rest Of Europe demonstrates consistent market expansion, though slightly below the global 12% CAGR, indicating regional maturity with sustained opportunities in emerging biotech hubs and contract manufacturing organizations.
Rest Of Europe Single-Use Bioreactors Market Dynamics
- Key growth factors include rising investments in biotech infrastructure, expanding contract manufacturing capabilities, and regulatory support for innovative production technologies across multiple European nations. The market's 7% CAGR reflects strong regional demand tempered by established manufacturing practices.
- Opportunities exist in emerging biotech clusters, particularly in Central and Eastern European countries, where single-use technologies offer cost-effective alternatives to traditional infrastructure.
- Continued consolidation among regional manufacturers and increasing adoption of disposable systems for personalized medicine and cell therapy production will further accelerate market growth through 2031..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Rest Of Europe's single-use bioreactors market will grow from USD 225.6 million (2026) to USD 316.4 million (2031) at a 7.0% CAGR.
- Rest Of Europe is increasingly adopting single-use technologies to reduce manufacturing costs and contamination risks in biopharmaceutical production.
- Cell and gene therapy expansion and CMO network growth are primary drivers accelerating single-use bioreactor demand across Rest Of Europe.
- Rest Of Europe's regulatory environment and post-pandemic supply chain investments position the region as a competitive biomanufacturing hub through 2031.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
Rest Of Europe Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Biopharmaceutical Manufacturers : Rest Of Europe-based biotech and pharma companies need regional market intelligence to benchmark production capabilities, evaluate single-use technology adoption, and optimize manufacturing strategies against regional competitors.
- Contract Manufacturing Organizations (CMOs) : CMOs operating in Rest Of Europe require detailed market data to assess demand for single-use bioreactor services, identify growth opportunities in emerging biotech clusters, and plan capacity expansion investments.
- Equipment & Technology Suppliers : Bioreactor manufacturers and disposable system providers need Rest Of Europe-specific insights to tailor product offerings, identify key customer segments, and develop targeted go-to-market strategies for the region.
- Investment & Private Equity Firms : Investors evaluating biotech and manufacturing opportunities in Rest Of Europe require comprehensive market data to assess growth potential, identify acquisition targets, and make informed capital allocation decisions.
- Healthcare Consultants & Advisors : Strategy consultants supporting clients in Rest Of Europe's biotech sector need regional market analysis to develop business plans, competitive positioning strategies, and market entry approaches.
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise valuation data specific to Rest Of Europe (USD 225.6M in 2026, USD 316.4M in 2031) with detailed 5-year projections to support strategic planning and investment decisions in the region.
- Competitive Landscape Analysis : Understand Rest Of Europe's competitive dynamics, including key manufacturers, market share distribution, and regional consolidation trends to identify partnership and acquisition opportunities.
- Country-Level Insights : Access granular analysis of individual Rest Of Europe markets, identifying high-growth countries and emerging biotech hubs where single-use bioreactor adoption is accelerating fastest.
- Regulatory & Compliance Framework : Gain insights into Rest Of Europe's regulatory environment, quality standards, and compliance requirements specific to single-use bioreactor manufacturing and validation across different nations.
- Growth Opportunity Mapping : Identify untapped segments and emerging applications within Rest Of Europe, including cell therapy, personalized medicine, and contract manufacturing opportunities driving market expansion.
Frequently asked questions
What is the market size of single-use bioreactors in Rest Of Europe?
Rest Of Europe's single-use bioreactors market was valued at USD 225.6 million in 2026 and is forecast to reach USD 316.4 million by 2031.
What is the expected growth rate for Rest Of Europe's single-use bioreactors market?
Rest Of Europe's single-use bioreactors market is expected to grow at a compound annual growth rate (CAGR) of 7.0% from 2026 to 2031.
What factors are driving growth in Rest Of Europe's single-use bioreactors market?
Rest Of Europe's market growth is driven by increased adoption of single-use technologies, expansion of cell and gene therapy manufacturing, growing CMO networks, and post-pandemic supply chain resilience investments.
Which industries in Rest Of Europe are adopting single-use bioreactors?
Rest Of Europe's biopharmaceutical manufacturers, contract manufacturing organizations (CMOs), and cell and gene therapy developers are the primary adopters of single-use bioreactor technology.
How does Rest Of Europe's market compare to global single-use bioreactors growth?
Rest Of Europe's 7.0% CAGR is lower than the global average of 12%, reflecting regional market maturity and specific regulatory and manufacturing dynamics unique to the region.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
